Guidelines

Therapy

Joint EANM/SNMMI/IAEA enabling guide: how to set up a theranostics centre (2022)

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds (2022)

The EANM guideline for radiosynoviorthesis (2021)

EANM procedure guidelines for radionuclide therapy with ¹⁷⁷Lu-labelled PSMA-ligands (¹⁷⁷Lu-PSMA-RLT) (2019)

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
(¹⁷⁷Lu-PSMA-RLT) (2018)

EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer (2018)

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (2013)

ERRATUM: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (2013)

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds (2011)

EANM procedure guidelines for therapy of benign thyroid disease (2010)

EANM procedure guidelines for ¹³¹I-meta-iodobenzylguanidine (¹³¹I-mIBG) therapy (2008)

Guidelines for radioiodine therapy of differentiated thyroid cancer (2008)

EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin) (2006)

This website uses cookies. Learn more